ADHD Trial, Recruiting NCT06194162 Sponsor: University Hospital Bispebjerg and Frederiksberg Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT06194162
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You (or your child's guardian) have agreed to take part by signing a consent form
  • The child is between 5 and 12 years old (inclusive) at the time of joining the trial
  • The child has been diagnosed with ADHD using specific recognised diagnostic codes (confirm with trial site)
  • Children who also have other health conditions alongside ADHD may still be eligible
  • The child has already tried a standard sleep advice programme managed by healthcare professionals in the last 6 months, but it did not help
  • If the child is currently taking ADHD medication and/or melatonin or other sleep medication, the dose must have been stable for at least two weeks before joining
  • Both the child and their caregiver can understand and communicate in Danish well enough to take part

Who may not be able to join:

  • The child has previously used any type of medically classified weighted blanket (Class 1 medical device)
  • The child has a diagnosed condition that would make it significantly difficult to take part in the study, such as intellectual disability, severe underweight, serious breathing or heart/circulation problems, surgical implants, or brittle bones (confirm with trial site if unsure)
  • Another person living in the same household is already enrolled in this trial

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ina O. Specht, Ph.d., Research Unit for Dietary Studies, The Parker Institute

Phone: +45 51197904

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital Bispebjerg and Frederiksberg
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
15 April 2026

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Changes in total sleep time (average minutes per day)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov